Therefore, reduced CD21 expression on CLL, is likely a mixture of transcriptional modifications [34], deletion of 11q [40], and increased activity of matrix metalloproteases [41], known to occur in CLL [42] and other disease scenarios such as RA/SLE [43]. The gene discussed is CR2; the disease is B-cell chronic lymphocytic leukemia.